Page 1098 - Williams Hematology ( PDFDrive )

1072 Part VIII: Monocytes and Macrophages Chapter 67: Structure, Receptors, and Functions of Monocytes and Macrophages 1073

87. Liu R, Paxton WA, Choe S, et al: Homozygous defect in HIV-1 coreceptor accounts for 121. Sidiropoulos PI, Goulielmos G, Voloudakis GK, et al: Inflammasomes and rheumatic
resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367–377, diseases: Evolving concepts. Ann Rheum Dis 67:1382–1389, 2008.
1996. 122. Ye Z, Ting JP: NLR, the nucleotide-binding domain leucine-rich repeat containing gene
88. Williams T, Rankin S: Chemokines and phagocyte trafficking, in Phagocyte–Pathogen family. Curr Opin Immunol 20:3–9, 2008.
Interactions: Macrophages and the Host Response to Infection, edited by Russell DG, 123. Ryan JG, Kastner DL: Fevers, genes, and innate immunity. Curr Top Microbiol Immunol
Gordon S, p 93. ASM Press, Washington, DC, 2009. 321:169–184, 2008.
89. Ross R: Atherosclerosis—An inflammatory disease. N Engl J Med 340:115–126, 1999. 124. Ogura Y, Inohara N, Benito A, et al: Nod2, a Nod1/Apaf-1 family member that is
90. Janeway CA Jr, Medzhitov R: Innate immune recognition. Annu Rev Immunol 20:197– restricted to monocytes and activates NF-kappaB. J Biol Chem 276:4812–4818, 2001.
216, 2002. 125. Inohara N, Ogura Y, Fontalba A, et al: Host recognition of bacterial muramyl dipeptide
91. Rebuck JW, Crowley JH: A method of studying leukocytic functions in vivo. Ann N Y mediated through NOD2. Implications for Crohn’s disease. J Biol Chem 278:5509–5512,
Acad Sci 59:757–805, 1955. 2003.
92. Boyden S: The chemotactic effect of mixtures of antibody and antigen on polymorpho- 126. Kzhyshkowska J, Krusell L: Cross-talk between endocytic clearance and secretion in
nuclear leucocytes. J Exp Med 115:453–466, 1962. macrophages. Immunobiology 214:576–593, 2009.
93. Jiang A, Bloom O, Ono S, et al: Disruption of E-cadherin-mediated adhesion induces a 127. Lieu ZZ, Lock JG, Hammond LA, et al: A trans-Golgi network golgin is required for the
functionally distinct pathway of dendritic cell maturation. Immunity 27:610–624, 2007. regulated secretion of TNF in activated macrophages in vivo. Proc Natl Acad Sci U S A
94. Hazenbos W, Brown E: Integrins on phagocytes, in Phagocyte–Pathogen Interactions: 105:3351–3356, 2008.
Macrophages and the Host Response to Infection, edited by Russell DG, Gordon S, p 137. 128. Stow JL, Low PC, Offenhauser C, Sangermani D: Cytokine secretion in macrophages
ASM Press, Washington, DC, 2009. and other cells: Pathways and mediators. Immunobiology 214:601–612, 2009.
95. Wheeler A, Ridley A: Leukocyte chemotaxis, in Phagocyte–Pathogen Interactions: Mac- 129. McPhail LC: SH3-dependent assembly of the phagocyte NADPH oxidase. J Exp Med
rophages and the Host Response to Infection, edited by Russell DG, Gordon S, p 183. 180:2011–2015, 1994.
ASM Press, Washington, DC, 2009. 130. O’Shea JJ, Murray PJ: Cytokine signaling modules in inflammatory responses. Immu-
96. Lattin JE, Schroder K, Su AI, et al: Expression analysis of G Protein-Coupled Receptors nity 28:477–487, 2008.
in mouse macrophages. Immunome Res 4:5, 2008. 131. Garcia-Sastre A, Biron CA: Type 1 interferons and the virus-host relationship: A lesson
97. Yona S, Lin HH, Siu WO, et al: Adhesion-GPCRs: Emerging roles for novel receptors. in detente. Science 312:879–882, 2006.
Trends Biochem Sci 33:491–500, 2008. 132. Bogdan C, Mattner J, Schleicher U: The role of type I interferons in non-viral infections.
98. Gordon S, Unkeless JC, Cohn ZA: Induction of macrophage plasminogen activator by Immunol Rev 202:33–48, 2004.
endotoxin stimulation and phagocytosis: Evidence for a two-stage process. J Exp Med 133. Dunn GP, Koebel CM, Schreiber RD: Interferons, immunity and cancer immunoedit-
140:995–1010, 1974. ing. Nat Rev Immunol 6:836–848, 2006.
99. Henson P, Bratton D: Recognition and removal of apoptotic cells, in Phagocyte–Patho- 134. Sharif MN, Tassiulas I, Hu Y, et al: IFN-alpha priming results in a gain of proinflamma-
gen Interactions: Macrophages and the Host Response to Infection, edited by Russell DG, tory function by IL-10: Implications for systemic lupus erythematosus pathogenesis. J
Gordon S, p 341. ASM Press, Washington, DC, 2009. Immunol 172:6476–6481, 2004.
100. Mariathasan S, Monack DM: Inflammasome adaptors and sensors: Intracellular regula- 135. Herrero C, Hu X, Li WP, et al: Reprogramming of IL-10 activity and signaling by IFN-
tors of infection and inflammation. Nat Rev Immunol 7:31–40, 2007. gamma. J Immunol 171:5034–5041, 2003.
101. Martinon F, Burns K, Tschopp J: The inflammasome: A molecular platform triggering 136. Martinez FO, Helming L, Gordon S: Alternative activation of macrophages: An immu-
activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10:417–426, nologic functional perspective. Annu Rev Immunol 27:451–483, 2009.
2002. 137. Varin A, Gordon S: Alternative activation of macrophages: Immune function and cellu-
102. Martinon F, Mayor A, Tschopp J: The inflammasomes: Guardians of the body. Annu Rev lar biology. Immunobiology 214:630–641, 2009.
Immunol 27:229–265, 2009. 138. Kaiser F, O’Garra A: Cytokines and macrophages and dendritic cells: Key modulators
103. Deretic V: Autophagy: A fundamental cytoplasmic sanitation process operational in of immune response, in Phagocyte–Pathogen Interactions: Macrophages and the Host
all cell types including macrophages, in Phagocyte–Pathogen Interactions: Macrophages Response to Infection, edited by Russell DG, Gordon S, p281–299. ASM Press, Washing-
and the Host Response to Infection, edited by Russell DG, Gordon S, p 419. ASM Press, ton, DC, 2009.
Washington, DC, 2009. 139. Lin DA, Boyce JA: Lysophospholipids as mediators of immunity. Adv Immunol 89:141–
104. Helming L, Winter J, Gordon S: The scavenger receptor CD36 plays a role in cytoki- 167, 2006.
ne-induced macrophage fusion. J Cell Sci 122:453–459, 2009. 140. Barclay AN, Wright GJ, Brooke G, Brown MH: CD200 and membrane protein interac-
105. Xia W, Hilgenbrink AR, Matteson EL, et al: A functional folate receptor is induced dur- tions in the control of myeloid cells. Trends Immunol 23:285–290, 2002.
ing macrophage activation and can be used to target drugs to activated macrophages. 141. Feldmann M: Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev
Blood 113:438–446, 2009. Immunol 2:364–371, 2002.
106. Kristiansen M, Graversen JH, Jacobsen C, et al: Identification of the haemoglobin scav- 142. Palladino MJ, Bower JE, Kreber R, Ganetzky B: Neural dysfunction and neurodegener-
enger receptor. Nature 409:198–201, 2001. ation in Drosophila Na+/K+ ATPase alpha subunit mutants. J Neurosci 23:1276–1286,
107. Tuluc F, Meshki J, Spitsin S, Douglas SD: HIV infection of macrophages is enhanced in 2003.
the presence of increased expression of CD163 induced by substance P. J Leukoc Biol 143. Balkwill F: Tumour necrosis factor and cancer. Nat Rev Cancer 9:361–371, 2009.
96:143–150, 2014. 144. Bongartz T, Sutton AJ, Sweeting MJ, et al: Anti-TNF antibody therapy in rheumatoid
108. Chimini G, Chavrier P: Function of Rho family proteins in actin dynamics during arthritis and the risk of serious infections and malignancies: Systematic review and
phagocytosis and engulfment. Nat Cell Biol 2:E191–E196, 2000. meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295:
109. Russell DG, Gordon S: Phagocyte–Pathogen Interactions: Macrophages and the Host 2275–2285, 2006.
Response to Infection. ASM Press, Washington, DC, 2009. 145. Gordon S, Fraser I, Nath D, et al: Macrophages in tissues and in vitro. Curr Opin Immu-
110. Ridley AJ, Hall A: Snails, Swiss, and serum: The solution for Rac ‘n’ Rho. Cell 116:S23– nol 4:25–32, 1992.
S25, 2 p following S25, 2004. 146. Lasser A: The mononuclear phagocytic system: A review. Hum Pathol 14:108–126,
111. Swanson JA: Shaping cups into phagosomes and macropinosomes. Nat Rev Mol Cell 1983.
Biol 9:639–649, 2008. 147. Fogelman AM, Van Lenten BJ, Warden C, et al: Macrophage lipoprotein receptors. J
112. Jutras I, Desjardins M: Phagocytosis: At the crossroads of innate and adaptive immu- Cell Sci Suppl 9:135–149, 1988.
nity. Annu Rev Cell Dev Biol 21:511–527, 2005. 148. Adams DO, Hamilton TA: Phagocytic cells: Cytotoxic activities of macrophages, in
113. Rohde K, Yates RM, Purdy GE, Russell DG: Mycobacterium tuberculosis and the envi- Inflammation: Basic Principles and Clinical Correlates, 2nd ed., edited by Gallin JI, Sny-
ronment within the phagosome. Immunol Rev 219:37–54, 2007. derman R, p 471. Raven Press, New York, 1992.
114. Bogdan C: Mechanisms and consequences of persistence of intracellular pathogens: 149. Werb Z, Goldstein I: Phagocytic cells: Chemotactic and effector functions of macro-
Leishmaniasis as an example. Cell Microbiol 10:1221–1234, 2008. phages and granulocytes, in Basic and Clinical Immunology, 7th ed., edited by Stites D,
115. Portnoy DA, Auerbuch V, Glomski IJ: The cell biology of Listeria monocytogenes infec- Terr A, p 96. Appleton and Lange, Norwalk, CT, 1991.
tion: The intersection of bacterial pathogenesis and cell-mediated immunity. J Cell Biol 150. Papadimitriou JM, Ashman RB: Macrophages: Current views on their differentiation,
158:409–414, 2002. structure, and function. Ultrastruct Pathol 13:343–372, 1989.
116. Swanson MS: Autophagy: Eating for good health. J Immunol 177:4945–4951, 2006. 151. Gordon S, Perry VH, Rabinowitz S, et al: Plasma membrane receptors of the mononu-
117. Steinman RM, Moberg CL: Zanvil Alexander Cohn 1926–1993. J Exp Med 179:1–30, 1994. clear phagocyte system. J Cell Sci Suppl 9:1–26, 1988.
118. Ganz T: Iron in innate immunity: Starve the invaders. Curr Opin Immunol 21:63–67, 2009. 152. Law SK: C3 receptors on macrophages. J Cell Sci Suppl 9:67–97, 1988.
119. Giodini A, Rahner C, Cresswell P: Receptor-mediated phagocytosis elicits cross-pre- 153. Hume DA, Ross IL, Himes SR, et al: The mononuclear phagocyte system revisited. J
sentation in nonprofessional antigen-presenting cells. Proc Natl Acad Sci U S A Leukoc Biol 72:621–627, 2002.
106:3324–3329, 2009. 154. Gordon S: Mononuclear phagocytes in rheumatic diseases, in Kelley’s Textbook of Rheu-
120. Helming L, Tomasello E, Kyriakides TR, et al: Essential role of DAP12 signaling in matology, edited by Firestein G, Budd RC, Harris ED Jr, McInnes IB, Ruddy S, Sergent
macrophage programming into a fusion-competent state. Sci Signal 1:ra11, 2008. JS, pp 135–154. WB Saunders, Philadelphia, 2008.

Kaushansky_chapter 67_p1043-1074.indd 1073 9/21/15 10:44 AM